<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00889941</url>
  </required_header>
  <id_info>
    <org_study_id>SU-02082009-1758</org_study_id>
    <nct_id>NCT00889941</nct_id>
  </id_info>
  <brief_title>Effect of Preoperative Pupil Size on Quality of Vision After Wavefront-Guided LASIK</brief_title>
  <official_title>Effect of Preoperative Pupil Size on Quality of Vision After Wavefront-Guided LASIK</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate whether the size of the pupil has an effect on&#xD;
      quality of vision in patients undergoing LASIK surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose: To prospectively evaluate the effect of preoperative pupil size on quality of vision&#xD;
      after wavefront-guided LASIK.&#xD;
&#xD;
      Methods: Fifty-one patients underwent LASIK for low myopia and completed questionnaires&#xD;
      regarding specific visual symptoms before and after surgery. Each eye was evaluated&#xD;
      postoperatively at 1-week, 1-, 3-, 6- and 12-months. Pupils were stratified according to&#xD;
      size: small (&lt;5.5mm), medium (5.5 to 6.0mm) and large (&gt;6.0mm). Mesopic pupil size and&#xD;
      preoperative and postoperative variables were evaluated using analysis of variance (ANOVA). A&#xD;
      regression model was also performed to determine the correlation between mean spherical&#xD;
      equivalent and cylinder and visual symptoms.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2004</start_date>
  <completion_date type="Actual">November 2005</completion_date>
  <primary_completion_date type="Actual">November 2005</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>small</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>medium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>large</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LASIK</intervention_name>
    <description>laser-assisted in situ keratomileusis</description>
    <arm_group_label>large</arm_group_label>
    <arm_group_label>medium</arm_group_label>
    <arm_group_label>small</arm_group_label>
    <other_name>laser-assisted in situ keratomileusis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. no more than 6.00 D of spherical myopia&#xD;
&#xD;
          2. no more than 3.00 D of refractive astigmatism&#xD;
&#xD;
          3. a stable refraction (less than 0.50D per year of sphere or cylinder)&#xD;
&#xD;
          4. a corneal diameter of less than 11.0 mm to allow for suction ring fixation&#xD;
&#xD;
          5. discontinuation of soft contact wear at least 7 days prior to preoperative evaluation&#xD;
&#xD;
          6. visual acuity correctable to at least 20/20&#xD;
&#xD;
          7. age older than 21 years&#xD;
&#xD;
          8. ability to participate in follow-up examinations for 12 months after LASIK surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. use of rigid gas permeable contact lens&#xD;
&#xD;
          2. severe dry eye symptoms&#xD;
&#xD;
          3. severe blepharitis&#xD;
&#xD;
          4. anterior segment abnormalities (i.e. cataracts, corneal scarring, or&#xD;
             neovascularization within 1 mm of intended ablation zone)&#xD;
&#xD;
          5. recurrent corneal erosion&#xD;
&#xD;
          6. severe basement membrane disease&#xD;
&#xD;
          7. progressive or unstable myopia or keratoconus&#xD;
&#xD;
          8. unstable corneal mires on central keratometry&#xD;
&#xD;
          9. corneal thickness in which LASIK procedure would result in less than 250 microns of&#xD;
             remaining posterior corneal thickness below the flap postoperatively&#xD;
&#xD;
         10. baseline standard manifest refraction of more than 0.75 D in sphere power&#xD;
&#xD;
         11. or a difference of greater than 0.50 D in cylinder power compared with baseline&#xD;
             standard cycloplegic refraction&#xD;
&#xD;
         12. a baseline standard cycloplegic refraction differing more than 0.75 in sphere, 0.50 D&#xD;
             in cylinder&#xD;
&#xD;
         13. have a different type of astigmatism (i.e. with-the-rule) when the cylinder is greater&#xD;
             than 0.50D compared to baseline standard cycloplegic refraction&#xD;
&#xD;
         14. preoperative assessment of ocular topography and/or aberrations indicates that either&#xD;
             eye is not suitable candidate for LASIK vision correction procedure (i.e. forme fruste&#xD;
             keratoconus&#xD;
&#xD;
         15. corneal warpage, or pellucid marginal degeneration)&#xD;
&#xD;
         16. previous intraocular or corneal surgery&#xD;
&#xD;
         17. history of herpes zoster or simplex keratitis&#xD;
&#xD;
         18. patients on systemic corticosteroid or immunosuppressive therapy&#xD;
&#xD;
         19. immunocompromised subjects or clinically significant atopic disease&#xD;
&#xD;
         20. connective tissue disease&#xD;
&#xD;
         21. diabetes&#xD;
&#xD;
         22. steroid responder&#xD;
&#xD;
         23. macular pathology&#xD;
&#xD;
         24. pregnant or lactating patients&#xD;
&#xD;
         25. patients with sensitivity to planned study concomitant medications&#xD;
&#xD;
         26. patients participating in another ophthalmic drug or device clinical trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annie Chan</last_name>
    <role>Sub-Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Edward E. Manche</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2009</verification_date>
  <study_first_submitted>February 12, 2009</study_first_submitted>
  <study_first_submitted_qc>April 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2009</study_first_posted>
  <last_update_submitted>April 28, 2009</last_update_submitted>
  <last_update_submitted_qc>April 28, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2009</last_update_posted>
  <responsible_party>
    <name_title>Edward Manche, MD</name_title>
    <organization>Stanford University</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

